A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)

Conditions: Neoplasms Interventions: Drug: TSR-022; Drug: Nivolumab; Drug: TSR-042; Drug: TSR-033; Drug: Docetaxel; Drug: Pemetrexed; Drug: Cisplatin; Drug: Carboplatin Sponsors: GlaxoSmithKline Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials